Sign inJoin waitlistJoin the waitlist

PW

Peter Westervelt

Professor of Medicine, Tufts University School of Medicine · MaineHealth

Credentials: · · · · ·

History

MaineHealth
Present

Hematology and Medical Oncology
Washington University School of Medicine
1996–1999
Internal Medicine
Washington University School of Medicine
1992–1993
Washington University School of Medicine
1988–1992

Research

Recurring mutations found by sequencing an acute myeloid leukemia genome
Case report · New England Journal of Medicine · 2009 · 1,846 citations
Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing
Nature · 2012 · 1,631 citations
DNMT3A mutations in acute myeloid leukemia
New England Journal of Medicine · 2010 · 1,622 citations

John DiPersio
117 papers
Geoffrey Uy
57 papers · 1 as a fellow
Ravi Vij
51 papers
Camille Abboud
49 papers
Amanda Cashen
47 papers
TL
Timothy Ley
47 papers
Keith Stockerl-Goldstein
40 papers
MW
Matthew Walter
40 papers
Daniel Link
39 papers
Mark Schroeder
35 papers
IP
Iskra Pusic
30 papers
Rizwan Romee
30 papers

Grants

Genomics Of Acute Myeloid Leukemia.
National Cancer Institute · P01
Project lead · $3.9M · Washington University
2003–2024
Specialized Program of Research Excellence (SPORE) in Leukemia
National Cancer Institute · P50
Project lead · $2M · Washington University
2013–2024
Phase III, Multicenter, Randomized, Double-Blind Study of Duvelisib as Cytokine Release Syndrome Prophylaxis in Patients with Large Cell or Mantle Cell Lymphoma Undergoing CAR T-Cell Therapies
National Heart, Lung, and Blood Institute · UG1
Contact PI · $1M · Washington University
2017–2024
Sargrastim and Plerixafor vs. Filgrastim for Allogeneic Stem Cell Mobilization
National Heart, Lung, and Blood Institute · U10
Contact PI · $937.1K · Washington University
2011–2017

Clinical trials

CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
Principal investigator · Completed · Phase 1
Washington University School of Medicine
2017–2019
Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant
Principal investigator · Completed · Phase 1
Washington University School of Medicine
2012–2015
Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML
Principal investigator · Completed · Phase 2
Chroma Therapeutics
2009–2011